Opportunities For Medtech In Mental Health
Executive Summary
With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. In Vivo explores transcranial magnetic stimulation systems that are being used to treat severe anxiety and depression, among other indications. As well as the skyrocketing use of telehealth, apps and light therapy for mental health indications.
You may also be interested in...
Rock Health Reports Record Digital Health Funding Of $5.4Bn In H1 2020, Sees Potential For Record-Year Funding
Digital health funding is on track for the largest funding year ever amid the COVID-driven demand for telehealth and remote monitoring of patients. However, a large second wave of the pandemic could reverse that trend.
OCD Indication Approved For Brainsway TMS Device
US FDA used its de novo review pathway to approve Brainsway Ltd.’s Brainsway Deep Transcranial Magnetic Stimulation System to treat obsessive compulsive disorder.
Playing Big: Akili To Be Bought By Chamath Palihapitiya’s SPAC In $1Bn Deal
Akili Interactive, which developed a video game to treat ADHD, will go public with one of Palihapitiya’s blank-check companies. The proceeds will be used to launch the FDA-cleared EndeavorRx digital therapeutics.